Seeking Alpha

  Sarepta Therapeutics, Inc. - NASDAQ

10/31/2014, 6:25 PM ET
  • freefdawatchlist | Send Message 24 Jul 2012 Premarket gainer $SRPT (117%), $HZNP (%%), $BIDU (5%), $R, $MNST, $BIIB, $GT, $RF,
      SRPT vs. ETF Alternatives
      Company Description
      Sarepta Therapeutics Inc discovers and develops RNA-based therapeutics for the treatment of rare and infectious diseases. Its product candidates include eteplirsen, AVI-6002, AVI-6003, and AVI-7100.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States